Co-diagnostics, inc. to participate in gilmartin group annual emerging growth showcase on sept 21

Salt lake city , sept. 21, 2023 /prnewswire/ -- co-diagnostics, inc. (nasdaq-cm: codx) (the "company" or "co-dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that co-diagnostics will be presenting at the gilmartin group annual emerging growth showcase.
CODX Ratings Summary
CODX Quant Ranking